Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection
Phase 2 Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Chronic Prosthetic Joint Infection of the Knee or Hip Without Exchange Arthroplasty
Sponsor: Trellis Bioscience LLC
Listed as NCT06621251, this PHASE2 trial focuses on Prosthetic Joint Infections of Hip and Prosthetic Joint Infections of Knee and remains actively recruiting participants. Sponsored by Trellis Bioscience LLC, it has been updated 9 times since 2025, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Nov 2025 — Present [monthly]
Recruiting PHASE2
-
Sep 2025 — Nov 2025 [monthly]
Recruiting PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE2
-
Jun 2025 — Aug 2025 [monthly]
Recruiting PHASE2
-
May 2025 — Jun 2025 [monthly]
Recruiting PHASE2
▶ Show 4 earlier versions
-
Apr 2025 — May 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2024 — Mar 2025 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Trellis Bioscience LLC
For direct contact, visit the study record on ClinicalTrials.gov .